Anna Eriksson

5.2k total citations · 2 hit papers
48 papers, 3.6k citations indexed

About

Anna Eriksson is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Anna Eriksson has authored 48 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Hematology and 8 papers in Cancer Research. Recurrent topics in Anna Eriksson's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Anna Eriksson is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). Anna Eriksson collaborates with scholars based in Sweden, Norway and Denmark. Anna Eriksson's co-authors include Erika Assarsson, Simon Fredriksson, Martin Lundberg, Yihai Cao, Renhai Cao, Kari Alitalo, Bonnie Robin Tran, Johan Björkesten, Mats Gullberg and Gabriella Edfeldt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Anna Eriksson

48 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability

2014 1.1k citations Erika Assarsson, Martin Lundberg et al. PLoS ONE profile →
Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood

2011 476 citations Martin Lundberg, Anna Eriksson et al. profile →

Peers

Countries citing papers authored by Anna Eriksson

Since Specialization

Citations

This map shows the geographic impact of Anna Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Eriksson more than expected).

Fields of papers citing papers by Anna Eriksson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Eriksson. The network helps show where Anna Eriksson may publish in the future.

Co-authorship network of co-authors of Anna Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Eriksson. A scholar is included among the top collaborators of Anna Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Eriksson. Anna Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia 2023 ·Clinical Cancer Research ·Anna Eriksson, (unknown), Lucy Mathot, (unknown), Martin Rippin, Lucia Cavelier, Claes Ladenvall, Panagiotis Baliakas	3
2	Managing leukemia patients via liquid biopsy and super rolling circle amplification (superRCA) 2023 ·Journal of Internal Medicine ·Anna Eriksson, (unknown), Rose‐Marie Amini, Lucia Cavelier, Ulf Landegren	2
3	SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people 2023 ·Research and Practice in Thrombosis and Haemostasis ·Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, (unknown), Magnus Kringstad Olsen, (unknown), (unknown), (unknown), Marie‐Christine Mowinckel, Maria Therese Ahlén, Ingvild Hausberg Sørvoll, (unknown), (unknown), (unknown), Benedicte Stavik, René Holst, Per Morten Sandset, Waleed Ghanima	3
4	Plasma protein biomarker profiling reveals major differences between acute leukaemia, lymphoma patients and controls 2022 ·New Biotechnology ·(unknown), Qiujin Shen, (unknown), (unknown), (unknown), Daniel Molin, (unknown), Eva Freyhult, Masood Kamali‐Moghaddam, Martin Höglund, Gunilla Enblad, Anna Eriksson	5
5	Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children 2022 ·Leukemia ·(unknown), Mattias Vesterlund, Husen M. Umer, Saeed Eshtad, Aron Skaftason, Morten Krogh Herlin, Christer Sundström, Anna Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe‐Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Cecilia Lindskog, Lucia Cavelier, Janne Lehtiö, Linda Holmfeldt	14
6	Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays 2022 ·Nature Communications ·(unknown), Anna Eriksson, Simone Weström, Tatjana Pandzic, Sören Lehmann, Lucia Cavelier, Ulf Landegren	19
7	A risk score based on real-world data to predict early death in acute promyelocytic leukemia 2022 ·Haematologica ·(unknown), (unknown), Anna Eriksson, Martin Jädersten, Vladimir Lazarević, Lovisa Wennström, Petar Antunović, Jörg Cammenga, Stefan Deneberg, Fryderyk Lorenz, Lars Möllgård, Bertil Uggla, (unknown), (unknown), (unknown), Martin Höglund, Gunnar Juliusson, Sylvain Lehmann	12
8	Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression 2021 ·Blood Advances ·(unknown), (unknown), (unknown), Jitong Sun, Aron Skaftason, Markus Mayrhofer, (unknown), Morten Krogh Herlin, Christer Sundström, Anna Eriksson, Martin Höglund, Josefine Palle, Jonas Abrahamsson, Kirsi Jahnukainen, Monica Cheng Munthe‐Kaas, Bernward Zeller, Katja Pokrovskaja Tamm, Lucia Cavelier, Jan Komorowski, Linda Holmfeldt	19
9	Is it possible to increase the amount of physical activity in patients isolated due to hematopoietic stem cell transplantation using a nursing intervention? A feasibility study 2021 ·Nordic journal of nursing research ·(unknown), Anna Eriksson, Karin Nordin, Birgitta Johansson	1
10	Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls 2019 ·Clinical Proteomics ·Tone Berge, Anna Eriksson, (unknown), Einar August Høgestøl, Pål Berg‐Hansen, Anne P. Døskeland, Olav Mjaavatten, Steffan D. Bos, Hanne F. Harbo, Frode S. Berven	25
11	Towards repositioning of quinacrine for treatment of acute myeloid leukemia – Promising synergies and in vivo effects 2017 ·Leukemia Research ·Anna Eriksson, (unknown), Mårten Fryknäs, Joachim Gullbo, Peter Nygren, Mats Gustafsson, Martin Höglund, Rolf Larsson	16
12	Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability breakdown → 2014 ·PLoS ONE ·Erika Assarsson, Martin Lundberg, Göran Holmquist, Johan Björkesten, (unknown), Daniel Ekman, Anna Eriksson, (unknown), (unknown), Gabriella Edfeldt, Ann‐Catrin Andersson, (unknown), Jan Stenvang, Mats Gullberg, Simon Fredriksson	1147
13	AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia 2013 ·Biochemical Pharmacology ·Anna Eriksson, Antonia Kalushkova, Malin Jarvius, Riet Hilhorst, Linda Rickardson, Hanna Göransson Kultima, Rik de Wijn, (unknown), Mårten Fryknäs, Fredrik Öberg, Rolf Larsson, Vendela Parrow, Martin Höglund	12
14	On the Roles and Regulation of Chondroitin Sulfate and Heparan Sulfate in Zebrafish Pharyngeal Cartilage Morphogenesis 2012 ·Journal of Biological Chemistry ·Katarina Holmborn, (unknown), Zsolt Kasza, Anna Eriksson, (unknown), Sandeep Gopal, John Couchman, Per Ahlberg, Małgorzata Wiweger, Dorothe Spillmann, Johan Kreuger, Johan Ledin	50
15	The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia 2012 ·Blood Cancer Journal ·Anna Eriksson, Monica Hermanson, Malin Wickström, Elin Lindhagen, (unknown), Annika Jenmalm Jensen, (unknown), Fredrik Lehmann, Rolf Larsson, Vendela Parrow, Martin Höglund	14
16	Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia 2011 ·PLoS ONE ·Heléne Hallböök, Jenny Felth, Anna Eriksson, Mårten Fryknäs, Lars Bohlin, Rolf Larsson, Joachim Gullbo	25
17	Identification of AKN-032, a novel 2-aminopyrazine tyrosine kinase inhibitor, with significant preclinical activity in acute myeloid leukemia 2010 ·Biochemical Pharmacology ·Anna Eriksson, Martin Höglund, Elin Lindhagen, Anna Åleskog, Sadia Hassan, (unknown), (unknown), Annika Jenmalm Jensen, (unknown), Martin Scobie, Rolf Larsson, Vendela Parrow	7
18	Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia 2008 ·European Journal Of Haematology ·Elin Lindhagen, Anna Eriksson, Malin Wickström, Katarina Danielsson, Birgitta Grundmark, Roger Henriksson, Peter Nygren, Anna Åleskog, Rolf Larsson, Martin Höglund	28
19	The CTA1-DD vaccine adjuvant binds to human B cells and potentiates their T cell stimulating ability 2003 ·Vaccine ·Anna Eriksson, Nils Lycke	20
20	Continuous Intravascular Secretion of Endostatin in Mice from Transduced Hematopoietic Stem Cells 2002 ·Molecular Therapy ·Robert Pawliuk, Thomas Bachelot, Omar Zurkiya, Anna Eriksson, Yihai Cao, Philippe Leboulch	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact